Viewing Study NCT07193550


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2025-12-29 @ 12:27 AM
Study NCT ID: NCT07193550
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-16
First Post: 2025-09-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module